← Open Payments lookup

EMILY REYNOLDS: Open Payments

NPI 1578827416 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$974 in 80 payments from 11 companies in 2025. Trend: 2023 $100 · 2024 $847 · 2025 $974

Food & beverage: $974
CompanyPaymentsAmount
ABBVIE INC.13$228
Teva Pharmaceuticals USA, Inc.43$183
Janssen Pharmaceuticals, Inc6$126
E.R. Squibb & Sons, L.L.C.4$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$73
Takeda Pharmaceuticals U.S.A., Inc.3$67
Neurocrine BioSciences, Inc.2$58
Alkermes, Inc.2$56
Luye Pharma (USA) Ltd.1$51
Otsuka America Pharmaceutical, Inc.1$27

Products named: VRAYLAR, AUSTEDO XR, INVEGA, COBENFY, CAPLYTA, TRINTELLIX, INGREZZA, ERZOFRI EXTENDED-RELEASE.

Industry payments across FL — which companies pay providers there.